IONIS PHARMACEUTICALS INC (IONS) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for IONIS PHARMACEUTICALS INC (IONS): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 33/100 — a percentile rank of IONIS PHARMACEUTICALS INC’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.
| Market cap | $7.4B |
| P / S | 8.5× |
| EV / EBITDA | -14.4× |
| Gross margin | 98.2% |
| Operating margin | -68.0% |
| Net margin | -64.7% |
| Return on equity | -128.5% |
| ROIC | -42.3% |
| Revenue growth | -7.4% |
| Debt / equity | 3.0× |
| Dividend yield | 0.0% |
Is IONIS PHARMACEUTICALS INC overvalued? P/S looks fair vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from IONIS PHARMACEUTICALS INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact